GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (FRA:NB3) » Definitions » 5-Year Yield-on-Cost %

Neurocrine Biosciences (FRA:NB3) 5-Year Yield-on-Cost % : 0.00 (As of May. 24, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Neurocrine Biosciences 5-Year Yield-on-Cost %?

Neurocrine Biosciences's yield on cost for the quarter that ended in Mar. 2024 was 0.00.


The historical rank and industry rank for Neurocrine Biosciences's 5-Year Yield-on-Cost % or its related term are showing as below:



FRA:NB3's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.13
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Neurocrine Biosciences's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Neurocrine Biosciences's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neurocrine Biosciences's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neurocrine Biosciences's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Neurocrine Biosciences's 5-Year Yield-on-Cost % falls into.



Neurocrine Biosciences 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Neurocrine Biosciences is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Neurocrine Biosciences  (FRA:NB3) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Neurocrine Biosciences 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Neurocrine Biosciences's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurocrine Biosciences (FRA:NB3) Business Description

Traded in Other Exchanges
Address
12780 El Camino Real, San Diego, CA, USA, 92130
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Neurocrine Biosciences (FRA:NB3) Headlines

No Headlines